Q1 2025 Holdings
Filed 2025-05-15 | 44 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $331.9M | 8,494,151 | 25.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $90.2M | 4,101,992 | 6.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $69.1M | 2,000,000 | 5.2% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $68.9M | 1,050,000 | 5.2% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $66.1M | 1,745,000 | 5.0% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $57.8M | 2,825,000 | 4.3% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $54.0M | 2,000,000 | 4.1% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $45.1M | 8,325,000 | 3.4% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $40.1M | 525,000 | 3.0% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $38.2M | 1,059,331 | 2.9% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $32.9M | 2,909,000 | 2.5% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $32.5M | 2,261,600 | 2.4% |
| Merus N V | COM | N5749R100 | $31.1M | 740,000 | 2.3% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $29.5M | 2,940,921 | 2.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $29.2M | 250,000 | 2.2% |
| Pharvaris N V(PHVS) | COM | N69605108 | $23.0M | 1,466,460 | 1.7% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $22.2M | 2,009,482 | 1.7% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $21.1M | 1,350,000 | 1.6% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $20.5M | 400,000 | 1.5% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $20.1M | 1,600,000 | 1.5% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $20.1M | 600,000 | 1.5% |
| CG Oncology Inc(CGON) | COM | 156944100 | $19.0M | 775,000 | 1.4% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $13.8M | 3,381,277 | 1.0% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $13.3M | 2,130,000 | 1.0% |
| Alumis Inc(ALMS) | COM | 022307102 | $13.2M | 2,147,396 | 1.0% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $12.6M | 2,375,000 | 0.9% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $11.8M | 400,000 | 0.9% |
| Metsera Inc | COM | 59267L107 | $10.9M | 400,000 | 0.8% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $10.4M | 2,323,595 | 0.8% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $9.9M | 2,629,529 | 0.7% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $7.9M | 150,000 | 0.6% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $7.9M | 1,837,739 | 0.6% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $7.6M | 3,570,872 | 0.6% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $6.6M | 380,303 | 0.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $6.6M | 175,000 | 0.5% |
| Aardvark Therapeutics Inc(AARD) | COM | 002942100 | $6.0M | 800,189 | 0.5% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $5.2M | 700,000 | 0.4% |
| Newamsterdam Pharma Company(NAMS)Call | ORDINARY SHARES | N62509109 | $5.1M | 250,000 | 0.4% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $4.9M | 250,000 | 0.4% |
| Janux Therapeutics Inc(JANX)Call | COM | 47103J105 | $4.1M | 150,000 | 0.3% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $4.1M | 3,000,000 | 0.3% |
| Kala BIO Inc(KALA) | COM NEW | 483119202 | $3.5M | 603,027 | 0.3% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $1.7M | 254,161 | 0.1% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $240.4K | 10,000 | 0.0% |